1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow TTP399: new trials by email Literature Review of TTP399 trials Research Report on TTP399
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Cadisegliatin 800 mg QD, Cadisegliatin 800 mg BID, Placebo - Diabetes Mellitus, Type 1 | Phase 3 | Active not recruiting | vTv Therapeutics | 150 | 2024-06-14 | 2026-11-02 |
vTv Therapeutics (1)
Puerto Rico (1) · United States (1)